BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2012
View Archived Issues
Novel FLAP inhibitors divulged by Boehringer Ingelheim
Read More
FKD Therapies clear to launch phase II Instiladrin study
Read More
Scientists in China links gene's expression levels to severity of cognitive impairment
Read More
Novel BACE inhibitor shows promise to treat Alzheimer's disease
Read More
Novel agents for hepatitis C prepared at Cocrystal Discovery
Read More
Spanish researchers patent new CB1 receptor ligands
Read More
Novel TLR7 agonists disclosed
Read More
Preclinical evaluation of OMS-824 complete
Read More
New antisense oligonucleotides designed at miRagen Therapeutics
Read More
Novel antivirals disclosed by Abbott
Read More
GSK vaccine candidate for shingles enters phase III study
Read More
MetaMax focuses on development of MM-D37K
Read More
Novel bile acid receptor agonists presented by IRM
Read More
Antinicotine gene therapy as a novel approach to nicotine addiction
Read More
Johnson & Johnson reviews highlights of second quarter 2012
Read More
NVP-BKM120 shows potential in models of follicular lymphoma
Read More
Milestone met in Amgen/Array BioPharma collaboration
Read More
Soricimed Biopharma to design biologic drug conjugates for oncology indications
Read More
FDA clears pivotal trials of sustained-release microinsert in uveitis
Read More
Phrixus Pharmaceuticals reports preclinical results for Carmeseal
Read More
Phase I trial commences of combination therapy for ovarian cancer
Read More
Phase I/II Actimab-A trial advances
Read More
Cytomedix collaborates with Duke University on brain cancer study
Read More
University of Alberta kicks off phase I/II study of pan-caspase inhibitor
Read More
NIH to test maraviroc-based drug regimens for HIV prevention
Read More
Sanofi and Regeneron launch phase III program for LDL-lowering antibody
Read More
Investigators at Bristol-Myers Squibb identify novel dAbs targeting CD40-L
Read More